• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯胺酮的作用机制:通往速效抗抑郁药之路。

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.

作者信息

Abdallah Chadi G, Adams Thomas G, Kelmendi Benjamin, Esterlis Irina, Sanacora Gerard, Krystal John H

机构信息

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.

Clinical Neuroscience Division, Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut.

出版信息

Depress Anxiety. 2016 Aug;33(8):689-97. doi: 10.1002/da.22501. Epub 2016 Apr 6.

DOI:10.1002/da.22501
PMID:27062302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4961540/
Abstract

Major depressive disorder (MDD) is a common and debilitating psychiatric disorder. Traditional antidepressants are of limited efficacy and take weeks to months to yield full therapeutic effects. Thus, there is a clear need for effective rapid-acting antidepressant medications. The N-methyl-d-aspartate receptor (NMDA-R) antagonist, ketamine, has received a great deal of attention over the last 20 years due to the discovery that a single subanesthetic dose leads to a rapid antidepressant effect in individuals with treatment-resistant depression. Animal and human research suggest that ketamine's antidepressant effects are mediated by a glutamate surge that leads to a cascade of events that result in synaptogenesis and reversal of the negative effects of chronic stress and depression, particularly within the prefrontal cortex (PFC). Preclinical and clinical data have provided compelling insights into the mechanisms underlying the rapid-acting antidepressant effects of ketamine. This review discusses stress-related neurobiology of depression and the safety, tolerability, and efficacy of ketamine for MDD, along with a review of ketamine's mechanism of action and prospective predictors of treatment response. Research limitations and future clinical prospects are also discussed.

摘要

重度抑郁症(MDD)是一种常见且使人衰弱的精神疾病。传统抗抑郁药疗效有限,需要数周甚至数月才能产生充分的治疗效果。因此,显然需要有效的速效抗抑郁药物。N-甲基-D-天冬氨酸受体(NMDA-R)拮抗剂氯胺酮在过去20年中受到了广泛关注,因为人们发现单次亚麻醉剂量的氯胺酮可使难治性抑郁症患者产生快速抗抑郁作用。动物和人体研究表明,氯胺酮的抗抑郁作用是由谷氨酸激增介导的,这会引发一系列事件,导致突触形成,并逆转慢性应激和抑郁症的负面影响,尤其是在前额叶皮质(PFC)内。临床前和临床数据为氯胺酮速效抗抑郁作用的潜在机制提供了令人信服的见解。本文综述了抑郁症与应激相关的神经生物学,以及氯胺酮治疗MDD的安全性、耐受性和疗效,并对氯胺酮的作用机制和治疗反应的前瞻性预测指标进行了综述。还讨论了研究局限性和未来的临床前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee43/4961540/bc2c10e5d227/nihms768441f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee43/4961540/db418b28f24e/nihms768441f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee43/4961540/bc2c10e5d227/nihms768441f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee43/4961540/db418b28f24e/nihms768441f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee43/4961540/bc2c10e5d227/nihms768441f2.jpg

相似文献

1
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.氯胺酮的作用机制:通往速效抗抑郁药之路。
Depress Anxiety. 2016 Aug;33(8):689-97. doi: 10.1002/da.22501. Epub 2016 Apr 6.
2
Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.快速作用抗抑郁药氯胺酮及其代谢物和其他候选药物:历史概述和未来展望。
Psychiatry Clin Neurosci. 2019 Oct;73(10):613-627. doi: 10.1111/pcn.12902. Epub 2019 Jul 11.
3
A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.氯胺酮在情感障碍中的应用综述:临床疗效的现有证据、使用限制以及作用机制的临床前证据。
J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10.
4
Ketamine: The final frontier or another depressing end?氯胺酮:是最终的前沿领域还是又一个令人沮丧的结局?
Behav Brain Res. 2020 Apr 6;383:112508. doi: 10.1016/j.bbr.2020.112508. Epub 2020 Feb 1.
5
What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.氯胺酮快速起效的抗抑郁作用机制是什么?对大量惊人可能性的简要概述。
J Clin Pharm Ther. 2017 Apr;42(2):147-154. doi: 10.1111/jcpt.12497. Epub 2017 Jan 22.
6
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.谷氨酸受体拮抗剂作为治疗抑郁症的快速起效治疗替代方案:氯胺酮及其他化合物。
Annu Rev Pharmacol Toxicol. 2014;54:119-39. doi: 10.1146/annurev-pharmtox-011613-135950.
7
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.氯胺酮滥用及其作为抗抑郁药使用背后的神经回路和分子机制存在重叠。
Behav Brain Res. 2020 Apr 20;384:112548. doi: 10.1016/j.bbr.2020.112548. Epub 2020 Feb 13.
8
An update on NMDA antagonists in depression.抗 NMDA 受体拮抗剂在抑郁症治疗中的研究进展。
Expert Rev Neurother. 2019 Nov;19(11):1055-1067. doi: 10.1080/14737175.2019.1643237. Epub 2019 Jul 22.
9
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.谷氨酸能神经传递:开发新型快速作用抗抑郁治疗方法的途径。
Int J Neuropsychopharmacol. 2019 Feb 1;22(2):119-135. doi: 10.1093/ijnp/pyy094.
10
Targeting glutamate signalling in depression: progress and prospects.靶向抑郁症谷氨酸信号:进展与展望。
Nat Rev Drug Discov. 2017 Jul;16(7):472-486. doi: 10.1038/nrd.2017.16. Epub 2017 Mar 17.

引用本文的文献

1
Oral Ketamine as a Treatment for Hyper-Responsiveness and Anxiety in a Female Allen's Swamp Monkey (Allenopithecus nigroviridis).口服氯胺酮治疗雌性艾伦沼泽猴(Allenopithecus nigroviridis)的反应过度和焦虑
Vet Med Sci. 2025 Sep;11(5):e70547. doi: 10.1002/vms3.70547.
2
A single subanaesthetic dose of the rapid-acting antidepressant S-ketamine raises presynaptic SV2A density in limbic regions of the Wistar Kyoto rat model of depression.单剂量亚麻醉剂量的速效抗抑郁药S-氯胺酮可提高Wistar Kyoto抑郁症大鼠模型边缘区域的突触前SV2A密度。
Neurosci Appl. 2024 Jun 20;3:104079. doi: 10.1016/j.nsa.2024.104079. eCollection 2024.
3

本文引用的文献

1
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.静脉注射氯胺酮治疗治疗抵抗性抑郁症的双盲、随机、安慰剂对照、剂量频率研究。
Am J Psychiatry. 2016 Aug 1;173(8):816-26. doi: 10.1176/appi.ajp.2016.16010037. Epub 2016 Apr 8.
2
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.静脉用依他佐辛治疗成人治疗抵抗性抑郁症:一项双盲、双随机、安慰剂对照研究。
Biol Psychiatry. 2016 Sep 15;80(6):424-431. doi: 10.1016/j.biopsych.2015.10.018. Epub 2015 Nov 3.
3
NMDA antagonist treatment of depression.
Hepatobiliary Complications Associated With Ketamine Use: Clinical Insights and Future Directions.
氯胺酮使用相关的肝胆并发症:临床见解与未来方向。
Cureus. 2025 May 28;17(5):e84974. doi: 10.7759/cureus.84974. eCollection 2025 May.
4
The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms.重度抑郁症的免疫学视角:揭示中枢与外周免疫机制之间的相互作用
J Neuroinflammation. 2025 Jan 19;22(1):10. doi: 10.1186/s12974-024-03312-3.
5
Chronic Corticosterone Administration-Induced Mood Disorders in Laboratory Rodents: Features, Mechanisms, and Research Perspectives.慢性皮质酮给药诱导的实验性啮齿动物情绪障碍:特征、机制及研究展望。
Int J Mol Sci. 2024 Oct 19;25(20):11245. doi: 10.3390/ijms252011245.
6
Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study.功能性活动和连接特征的氯胺酮和拉莫三嗪在负面情绪处理期间:一项双盲随机对照 fMRI 研究。
Transl Psychiatry. 2024 Oct 14;14(1):436. doi: 10.1038/s41398-024-03120-6.
7
Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders.抗抑郁药衍生物合成的最新进展:情绪障碍的药理学见解
3 Biotech. 2024 Nov;14(11):260. doi: 10.1007/s13205-024-04104-5. Epub 2024 Oct 5.
8
TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis.TAARs作为治疗抑郁症的新型治疗靶点:与单胺和成人神经发生相互关系的叙述性综述
Biomedicines. 2024 Jun 6;12(6):1263. doi: 10.3390/biomedicines12061263.
9
A qualitative investigation of the Montgomery-Åsberg depression rating scale: discrepancies in rater perceptions and data trends in remote assessments of rapid-acting antidepressants in treatment resistant depression.蒙哥马利-奥斯伯格抑郁评定量表的定性研究:难治性抑郁症中快速起效抗抑郁药远程评估中评估者认知与数据趋势的差异
Front Psychiatry. 2024 May 1;15:1289630. doi: 10.3389/fpsyt.2024.1289630. eCollection 2024.
10
Effect of Acute Ketamine Treatment on Sympathetic Regulation Indexed by Electrodermal Activity in Adolescent Major Depression.急性氯胺酮治疗对青少年重度抑郁症患者以皮肤电活动为指标的交感神经调节的影响。
Pharmaceuticals (Basel). 2024 Mar 10;17(3):358. doi: 10.3390/ph17030358.
NMDA拮抗剂治疗抑郁症。
Curr Opin Neurobiol. 2016 Feb;36:112-7. doi: 10.1016/j.conb.2015.11.001. Epub 2015 Dec 11.
4
Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression.氯胺酮治疗单相和双相抑郁的短期和中期疗效的荟萃分析。
Psychiatry Res. 2015 Dec 15;230(2):682-8. doi: 10.1016/j.psychres.2015.10.032. Epub 2015 Oct 30.
5
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.氯胺酮和其他 NMDA 拮抗剂:抑郁症的早期临床试验和可能的机制。
Am J Psychiatry. 2015 Oct;172(10):950-66. doi: 10.1176/appi.ajp.2015.15040465.
6
A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.一项关于氨基酸神经递质对氯胺酮治疗重度抑郁症反应的体内质子磁共振波谱初步研究。
Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.
7
Ketamine inside neurons?神经元内的氯胺酮?
Am J Psychiatry. 2015 Nov 1;172(11):1064-6. doi: 10.1176/appi.ajp.2015.14121537. Epub 2015 Jul 17.
8
Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions.光遗传学刺激边缘下前额叶皮层可重现氯胺酮快速且持久的抗抑郁作用。
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8106-11. doi: 10.1073/pnas.1414728112. Epub 2015 Jun 8.
9
Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder.前额叶皮质γ-氨基丁酸异常与重度抑郁症患者海马体积减小有关。
Eur Neuropsychopharmacol. 2015 Aug;25(8):1082-90. doi: 10.1016/j.euroneuro.2015.04.025. Epub 2015 May 5.
10
Ketamine Strengthens CRF-Activated Amygdala Inputs to Basal Dendrites in mPFC Layer V Pyramidal Cells in the Prelimbic but not Infralimbic Subregion, A Key Suppressor of Stress Responses.氯胺酮增强了前边缘而非边缘下亚区域中内侧前额叶皮质第V层锥体细胞基底树突上促肾上腺皮质激素释放因子激活的杏仁核输入,边缘下亚区域是应激反应的关键抑制因子。
Neuropsychopharmacology. 2015 Aug;40(9):2066-75. doi: 10.1038/npp.2015.70. Epub 2015 Mar 11.